Hyoscine
DrugThe samples were randomly allocated to inject of 20 mg of hyoscineIM in dilatation 3-5cm.
NCT Number: NCT01644838
It is always considered to shorten the duration of delivery without compromising the mother and fetus by obstetrics. Hyoscine and Promethazine are used widely in hospital and research is very limited, with conflicting results regarding the efficacy of these two drugs. So the investigators decided to compare of effect of hyoscine N-butyl bromide and Promethazine on length of active phase of the first stage of labor.
Looking for future studies?
Notify Me18 year–35 year
Female
Interventional
Phase 2 / Phase 3
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The samples were randomly allocated to inject of 20 mg of hyoscineIM in dilatation 3-5cm.
The samples were randomly allocated to inject of 25 mg of promethazine IM in dilatation 3-5cm.
Time frame: up to 9 months
Mashhad University of Medical Sciences
Other
Principal Investigator
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05155826
Delivery Problem, Dystocia
Saint-Etienne, France
View Trial DetailsNCT07647809
Back Pain, Depression, Postpartum
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06304311
Labor Pain, Neurologic Manifestations
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05606952
Labor Pain, Neurologic Manifestations
Menoufia, Egypt
View Trial Details